Fidelity Funds - American Growth Fund A-Acc-USDRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.7 | 21.7 | -3.0 | 5.1 | 5.0 | |
+/-Cat | -1.4 | 2.2 | 9.2 | -8.3 | 0.4 | |
+/-B’mrk | - | -4.5 | 6.7 | -13.4 | -2.1 | |
Category: US Flex-Cap Equity | ||||||
Category Benchmark: Morningstar US Market Ext N... |
Key Stats | ||
NAV 02/05/2024 | USD 32.75 | |
Day Change | 0.67% | |
Morningstar Category™ | US Flex-Cap Equity | |
ISIN | LU0275693405 | |
Fund Size (Mil) 31/03/2024 | USD 910.21 | |
Share Class Size (Mil) 02/05/2024 | USD 110.11 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 02/02/2024 | 1.90% |
Investment Objective: Fidelity Funds - American Growth Fund A-Acc-USD |
The fund aims to achieve capital growth over the long term. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Aditya Khowala 21/12/2012 | ||
Anee Das 01/06/2022 | ||
Inception Date 04/12/2006 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 NR USD | Morningstar US Market Ext NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fidelity Funds - American Growth Fund A-Acc-USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
RenaissanceRe Holdings Ltd | Financial Services | 3.48 |
Schlumberger Ltd | Energy | 3.19 |
AstraZeneca PLC | Healthcare | 3.10 |
NVIDIA Corp | Technology | 3.10 |
Boston Scientific Corp | Healthcare | 3.02 |
Increase Decrease New since last portfolio | ||
Fidelity Funds - American Growth Fund A-Acc-USD |